We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NATI
151
DELISTED
National Instruments Corp
NATI
$866K 0.08%
+27,719
New +$982K
SWI
152
DELISTED
SolarWinds Corporation Common Stock
SWI
$855K 0.08%
83,416
+39,250
+89% +$466K
UAA icon
153
Under Armour
UAA
$2.6B
$849K 0.08%
+101,974
New +$1.25M
VKTX icon
154
Viking Therapeutics
VKTX
$4B
$849K 0.08%
293,648
+196,977
+204% +$487K
VTRS icon
155
Viatris
VTRS
$18.9B
$848K 0.08%
+81,017
New +$888K
ADSK icon
156
Autodesk
ADSK
$52.6B
$847K 0.08%
4,923
-780
-14% -$150K
UNP icon
157
Union Pacific
UNP
$174B
$843K 0.08%
+3,953
New +$899K
WBD icon
158
Warner Bros
WBD
$67.1B
$843K 0.08%
+62,832
New +$1.17M
KOD icon
159
Kodiak Sciences
KOD
$2.84B
$831K 0.08%
+108,798
New +$764K
ERIE icon
160
Erie Indemnity
ERIE
$13.2B
$829K 0.08%
4,314
+2,589
+150% +$450K
TWTR
161
CALL
DELISTED
Twitter, Inc.
TWTR
$823K 0.08%
+22,000
New +$944K
AKAM icon
162
Akamai
AKAM
$15.9B
$819K 0.08%
+8,963
New +$934K
BRK.B icon
163
Berkshire Hathaway Class B
BRK.B
$1.13T
$819K 0.08%
3,000
+869
+41% +$273K
PFSI icon
164
PennyMac Financial
PFSI
$4.02B
$815K 0.08%
+18,657
New +$881K
PRG icon
165
PROG Holdings
PRG
$1.71B
$813K 0.08%
49,248
+22,760
+86% +$582K
TFX icon
166
Teleflex
TFX
$5.98B
$809K 0.08%
+3,292
New +$959K
VYGR icon
167
Voyager Therapeutics
VYGR
$201M
$807K 0.08%
136,592
XOM icon
168
ExxonMobil
XOM
$634B
$806K 0.08%
9,408
+3,483
+59% +$314K
MOMO
169
Hello Group
MOMO
$866M
$805K 0.08%
159,347
+16,086
+11% +$84.3K
XRAY icon
170
Dentsply Sirona
XRAY
$2.43B
$804K 0.08%
+22,491
New +$910K
AMGN icon
171
Amgen
AMGN
$222B
$802K 0.08%
+3,296
New +$808K
LBTYA icon
172
Liberty Global Class A
LBTYA
$3.6B
$801K 0.08%
+38,039
New +$893K
PYPL icon
173
PayPal
PYPL
$50.5B
$801K 0.08%
11,462
+5,752
+101% +$499K
ANF icon
174
Abercrombie & Fitch
ANF
$5B
$793K 0.08%
+46,893
New +$1.29M
TXN icon
175
Texas Instruments
TXN
$261B
$787K 0.08%
+5,125
New +$862K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.